Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Intercure Ltd.✕ INCR · #21,184 in the world |
|---|---|
| Profile | |
| Country | 🇮🇱 Israel |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | — |
| Size | |
| Market cap | $51 M |
| Revenue | $65 M |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Intercure Ltd. |
|---|---|
| 2024 | $65 MSEC |
| 2023 | $96 MSEC |
| 2022 | $116 MSEC |
| 2021 | $68 MSEC |
| 2020 | $19 MSEC |
| 2019 | $3 MSEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $-18 M |
| Valuation | |
|---|---|
| Price to sales | 0.8× |
| Price to book | 0.5× |
| Free cash flow yield | -37.4% |
| Profitability | |
|---|---|
| Gross margin | 12.7% |
| Operating margin | -28.1% |
| Net margin | -28.4% |
| Return on equity | -15.6% |
| Growth | |
|---|---|
| Revenue growth | -33.0% |
| Revenue growth, 3 years a year | -1.7% |
| Financial strength | |
|---|---|
| Debt to equity | 0.3× |
| Cash | |
|---|---|
| Free cash flow margin | -29.9% |
| Altman Z-score zone | — |
|---|
| Data as of | Market cap Aug 2026; ratios FY2024 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.